{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:57:41Z","timestamp":1777352261569,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jaci.2019.11.018","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T20:12:44Z","timestamp":1574712764000},"page":"481-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Omalizumab safety in pregnancy"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0620-2810","authenticated-orcid":false,"given":"Francesca","family":"Levi-Schaffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mankuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.11.018_bib1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaci.2019.05.019","article-title":"Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort","volume":"145","author":"Namazy","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.11.018_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1398-9995.2010.02522.x","article-title":"Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma","volume":"66","author":"Bousquet","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.11.018_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaci.2014.08.025","article-title":"The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy","volume":"135","author":"Namazy","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.11.018_bib4","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1016\/j.jaip.2019.05.043","article-title":"Poorly controlled asthma during pregnancy remains common in the United States","volume":"7","author":"Cohen","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2019.11.018_bib5","first-page":"145","article-title":"Omalizumab use during pregnancy for CIU: a tertiary care experience","volume":"48","author":"Cuervo-Pardo","year":"2016","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.11.018_bib6","doi-asserted-by":"crossref","first-page":"985646","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jaci.2019.11.018_bib7","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/cea.12508","article-title":"Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti-IgE\/IgE immune complexes","volume":"45","author":"Bundhoo","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.11.018_bib8","doi-asserted-by":"crossref","first-page":"e104755","DOI":"10.1371\/journal.pone.0104755","article-title":"Asthma during pregnancy in a population-based study\u2014pregnancy complications and adverse perinatal outcome","volume":"9","author":"Rejn\u00f6","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2019.11.018_bib9","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jaci.2015.05.043","article-title":"Use of asthma medication during pregnancy and risk of specific congenital anomalies: a European case-malformed control study","volume":"136","author":"Garne","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.11.018_bib10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1471-0528.12224","article-title":"The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis","volume":"120","author":"Murphy","year":"2013","journal-title":"BJOG"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919316008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919316008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:23:35Z","timestamp":1758792215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919316008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0091674919316008"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.11.018","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omalizumab safety in pregnancy","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.05.019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}